Johnson & Johnson Covid-19 vaccine is 66% effective in worldwide trials, but 85% effective against serious diseases, says the company
Modern doubles on Covid-19 with new booster trials; Australia plans domestic production of AstraZeneca vaccine amid distribution backlogs – Endpoints News
Faculty of Medicine of UMass is one of the clinical trials of vaccine of Moderna – Telemundo Nueva Inglaterra